Sysmex Corp (6869):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sysmex Corp (6869) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11467
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include heamatology, hemostasis, urinalysis analyzers. It conducts research and development at its facilities in Japan, North America and Europe. The company operates along with its subsidiaries in the Americas, Europe, Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

Sysmex Corp (6869) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sysmex Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9
Sysmex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sysmex Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 11
Sysmex Inostics Enters into Distribution Agreement with IndivuTest 12
Merck Serono Enters into Co-Development Agreement with Sysmex Inostics 13
Sysmex Corp – Key Competitors 14
Sysmex Corp – Key Employees 15
Sysmex Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 19
Recent Developments 20
Strategy And Business Planning 20
Aug 16, 2018: Sysmex America opens “Center for Learning,” expanding training facilities for customers in North America 20
Jul 10, 2018: Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services 22
Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities 23
Financial Announcements 24
May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 24
Corporate Communications 27
Mar 08, 2018: Sysmex: Announcement of Organizational and Personnel Changes 27
Legal and Regulatory 29
Apr 24, 2018: Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers 29
Other Significant Developments 31
Sep 05, 2017: Sysmex Begins Conducting Direct Sales and Services in Ghana 31
Aug 17, 2017: Sysmex to Commence Sales of “Revohem PT” Reagent for Measuring Prothrombin Time, a Key Testing Parameter for Monitoring Anticoagulation Therapy 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Sysmex Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sysmex Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sysmex Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9
Sysmex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 11
Sysmex Inostics Enters into Distribution Agreement with IndivuTest 12
Merck Serono Enters into Co-Development Agreement with Sysmex Inostics 13
Sysmex Corp, Key Competitors 14
Sysmex Corp, Key Employees 15
Sysmex Corp, Other Locations 16
Sysmex Corp, Subsidiaries 17
Sysmex Corp, Joint Venture 19

List of Figures
Sysmex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sysmex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sysmex Corp (6869):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • East Kentucky Power Cooperative Inc:企業の戦略的SWOT分析
    East Kentucky Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • VQ OrthoCare:企業の戦略的SWOT分析
    VQ OrthoCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pioneer Corporation:企業の戦略・SWOT・財務情報
    Pioneer Corporation - Strategy, SWOT and Corporate Finance Report Summary Pioneer Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Franklin Covey Co. (FC):企業の財務・戦略的SWOT分析
    Franklin Covey Co. (FC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Akers Biosciences Inc (AKER):医療機器:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers. The company develops first-in-class products utilizing its proprietary technology NanoXray, based on the physical mode of action of nanoparticles that increase the X-rays do …
  • Valora Holding AG (VALN):企業の財務・戦略的SWOT分析
    Valora Holding AG (VALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nymox Pharmaceutical Corp (NYMX):医療機器:M&Aディール及び事業提携情報
    Summary Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the …
  • Aileron Therapeutics Inc (ALRN)-製薬・医療分野:企業M&A・提携分析
    Summary Aileron Therapeutics Inc (Aileron) is a biopharmaceutical company that develops and commercializes novel class of therapeutics. The company provides products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protein-protein int …
  • Vericel Corp (VCEL)-医療機器分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Indivumed GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Indivumed GmbH (Indivumed) is an oncology company that provides solutions for diagnosis and treatment of cancer. The company is involved in the generation, characterization, and analysis of biologic samples from human cancer patients. It offers biospecimen products and clinical data sets; an …
  • Sensus Healthcare Inc (SRTS):企業の財務・戦略的SWOT分析
    Sensus Healthcare Inc (SRTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務分析
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • TBC Insurance JSC:企業の戦略的SWOT分析
    TBC Insurance JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • moksha8 Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Moksha8 Pharmaceuticals Inc (Moksha8) is a specialty pharmaceutical company that offers therapeutic products. The company manufactures and commercializes products for the treatment of critical diseases. It provides vilazodone HCI for depressive disorder. Moksha8 commercialize a portfolio of …
  • Barnes & Noble Education Inc (BNED):企業の財務・戦略的SWOT分析
    Barnes & Noble Education Inc (BNED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lotte Holdings Co. Ltd.:企業の戦略・SWOT・財務情報
    Lotte Holdings Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lotte Holdings Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Northam Platinum Limited:企業の戦略・SWOT・財務情報
    Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CommScope Holding Company Inc (COMM):企業の財務・戦略的SWOT分析
    CommScope Holding Company Inc (COMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆